Literature DB >> 4349225

Chemotherapy of cutaneous herpesvirus infection of hairless mice.

M Lieberman, T W Schafer, P E Came.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1973        PMID: 4349225     DOI: 10.1111/1523-1747.ep12724476

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN: 0022-202X            Impact factor:   8.551


× No keyword cloud information.
  14 in total

1.  Phosphonoacetic acid-resistant herpes simplex virus infection in hairless mice.

Authors:  R J Klein; A E Friedman-Kien
Journal:  Antimicrob Agents Chemother       Date:  1975-03       Impact factor: 5.191

2.  Herpesvirus hominis infection in newborn mice: comparison of the therapeutic efficacy of 1-beta-D-arabinofuranosylcytosine and 9-beta-D-arabinofuranosyladenine.

Authors:  E R Kern; J C Overall; L A Glasgow
Journal:  Antimicrob Agents Chemother       Date:  1975-05       Impact factor: 5.191

3.  Skin structure and metabolism: relevance to the design of cutaneous therapeutics.

Authors:  D A Bucks
Journal:  Pharm Res       Date:  1984-07       Impact factor: 4.200

4.  Recurrent cutaneous herpes simplex in hairless mice.

Authors:  G E Underwood; S D Weed
Journal:  Infect Immun       Date:  1974-09       Impact factor: 3.441

5.  Herpes simplex virus skin infection in hairless mice: treatment with antiviral compounds.

Authors:  R J Klein; A E Friedman-Kien; E Brady
Journal:  Antimicrob Agents Chemother       Date:  1974-03       Impact factor: 5.191

6.  Gastrointestinal invasion by herpes simplex virus type 1 inoculated cutaneously into the immunosuppressed mice.

Authors:  H Takase; E Yamamura; Y Murakami; T Ikeuchi; Y Osada
Journal:  Arch Virol       Date:  1994       Impact factor: 2.574

7.  Novel animal model for evaluating topical efficacy of antiviral agents: flux versus efficacy correlations in the acyclovir treatment of cutaneous herpes simplex virus type 1 (HSV-1) infections in hairless mice.

Authors:  P H Lee; M H Su; E R Kern; W I Higuchi
Journal:  Pharm Res       Date:  1992-08       Impact factor: 4.200

8.  Estimation of skin target site acyclovir concentrations following controlled (trans)dermal drug delivery in topical and systemic treatment of cutaneous HSV-1 infections in hairless mice.

Authors:  G Imanidis; W Q Song; P H Lee; M H Su; E R Kern; W I Higuchi
Journal:  Pharm Res       Date:  1994-07       Impact factor: 4.200

9.  Activities of 5,6-dihydro-5-azathymidine against herpes simplex virus infections in mice.

Authors:  H E Renis; E E Eidson
Journal:  Antimicrob Agents Chemother       Date:  1979-02       Impact factor: 5.191

10.  Iontophoretic application of adenine arabinoside monophosphate to herpes simplex virus type 1-infected hairless mouse skin.

Authors:  N H Park; L P Gangarosa; B S Kwon; J M Hill
Journal:  Antimicrob Agents Chemother       Date:  1978-10       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.